Loading...
EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
The paper analyzes the data available in the literature on the mechanisms of action of certolizumab pegol (CZP), a new tumor necrosis factor-α (TNF-α) inhibitor for the treatment of active psoriatic arthritis (PsA). It describes the unique molecular structure of the drug and its mechanism of action...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
IMA-PRESS LLC
2015-10-01
|
| Serier: | Научно-практическая ревматология |
| Fag: | |
| Online adgang: | https://rsp.mediar-press.net/rsp/article/view/2132 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|